A strategic planning and decision-support tool that delivers early Budget Impact Analysis (BIA) insights, enabling manufacturers to make timely, informed decisions that enhance commercial viability and maintain strategic alignment throughout drug development.
AI-driven market intelligence and landscape assessment platform, enabling opportunity discovery and launch planning in the fast-evolving Digital Therapeutics (DTx) sector.
For the Pharma Sector, we’re thrilled to launch KStrategy & AccessOPTI - BIA, an advanced strategic planning and decision-support tool rooted in insights from Budget Impact Analysis.
+44 (0)73657 31603
71-75, Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ